Memo Therapeutics identifies potent SARS-CoV-2-neutralising antibodies from blood of recovered Covid-19 patients

Memo Therapeutics has identified potent SARS-CoV-2-neutralising antibodies from blood of recovered Covid-19 patients. (Credit: Gerd Altmann from Pixabay)